InvestorsHub Logo
Followers 6
Posts 760
Boards Moderated 0
Alias Born 07/18/2006

Re: None

Thursday, 10/05/2017 9:47:06 AM

Thursday, October 05, 2017 9:47:06 AM

Post# of 20689
It is probably reasonable to expect approval of MNTA 40 mg in the near future but since anticipated model of only one generic, not two at least initially would be off the table, can we anticipate an "authorized generic" from TEVA at that point? Anyone able to offer a model of what that market would look like? This appears to have been a long run for a short slide. Future value creating events do not seem apparent over the short to immediate term. (2020?) Keep smiling. bp